Financhill
Back

Catalyst Pharmaceuticals Vs. Cytokinetics Industry Stock Comparison

Sell
46

CPRX
Catalyst Pharmaceuticals

Last Price:
15.01
Seasonality Move:
10.94%
Sell
45

CYTK
Cytokinetics

Last Price:
64.29
Seasonality Move:
12.64%
Sell
46
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $15.20. The Score for CPRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $63.37. The Score for CYTK is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $15.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing slight selling pressure.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $63.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 48.32 Sell
Chaikin Money Flow: -120105 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.98 - 15.78) Sell
Bollinger Bands (100): (14.07 - 16.21) Buy

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2 Sell
Relative Strength Index (14 RSI): 39.34 Sell
Chaikin Money Flow: 446915 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (65.12 - 72.68) Sell
Bollinger Bands (100): (55.2 - 85.66) Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15 Buy
20-day SMA: 15.3 Sell
50-day SMA: 15.57 Sell
200-day SMA: 14.24 Buy
8-day EMA: 15.11 Buy
20-day EMA: 15.27 Sell
50-day EMA: 15.31 Sell
200-day EMA: 14.6 Buy

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.51 Sell
20-day SMA: 68.3 Sell
50-day SMA: 69.18 Sell
200-day SMA: 51.66 Buy
8-day EMA: 64.44 Sell
20-day EMA: 66.78 Sell
50-day EMA: 68.53 Sell
200-day EMA: 57.55 Buy

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.31 per share, and an increase next year of $1.28 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):